DDInter948 DDInter781
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Fosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy.
Fosinopril {u} (Compound) resembles {v} (Compound) Enalapril
Fosinopril {u} (Compound) resembles {v} (Compound) Spirapril
Fosinopril {u} (Compound) treats {v} (Disease) hypertension
Fosinopril {u} (Compound) binds {v} (Gene) SLC15A1
Fosinopril {u} (Compound) upregulates {v} (Gene) SYNGR3
Fosinopril {u} (Compound) causes {v} (Side Effect) Urticaria
Fosinopril (Compound) resembles Enalapril (Compound)
Fosinopril (Compound) resembles Spirapril (Compound)
Fosinopril (Compound) treats hypertension (Disease)
Fosinopril (Compound) binds SLC15A1 (Gene)
Fosinopril (Compound) upregulates SYNGR3 (Gene)
Fosinopril (Compound) causes Urticaria (Side Effect)